UNSPSC 51332809: Clospirazine or spiclomazine

This classification denotes an antipsychotic agent with the molecular formula C22H24ClN3OS2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G2V8248111, chemically known as 8-(3-(2-chloro-10-phenothiazinyl)propyl)-1-thia-4,8-diazaspiro(4,5)decan-3-one but generally known as clospirazine, which bears US NIH Compound Identifier 65714. European Medicines Agency schedules Spiclomazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10616MIG.

The term SPICLOMAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25, No. 10 1971, List 11). Clospirazine or spiclomazine bears US NLM identifiers UMLS ID C1883076 and NCI Concept Code C66557. SMILES: C1CN(CCC12NC(=O)CS2)CCCN3C4=CC=CC=C4SC5=C3C=C(C=C5)CL.

UNSPSC 51332809 Clospirazine or spiclomazine is a Commodity code reflecting pharmaceutical products used in emergency response and community health interventions, though recent state and local solicitations under this code show minimal activity aligned with its nominal scope. The code appears underutilized or misapplied in current state and local procurement, as the single recent opportunity on file—Seminole County, Florida's IFB60459723LAS—seeks naloxone and drug deactivation systems rather than the antipsychotic compounds the code nominally describes. The mismatch between the code's pharmaceutical classification and the actual goods being solicited suggests either mistagging in the opportunity posting or a broader application of the code to emergency-response pharmaceuticals that extends beyond its stated substance name.

Seminole County, a Florida county government, posted the naloxone procurement as an IFB on June 30, 2026, with a response deadline of July 26, 2023 (note: the date appears to contain a data inconsistency, as the posting date is substantially after the response deadline). The county seeks annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems delivered quarterly to the Seminole County Community Health Building in Sanford, Florida, with shipping and delivery costs included in vendor proposals. The contract carries a two-year initial term with an optional one-year renewal, requires E-Verify compliance and drug-free workplace certification, and includes FEMA funding with corresponding federal compliance obligations. No explicit set-aside designations for disadvantaged enterprises are noted. No other state or local opportunities under this code are visible in the recent record, indicating minimal current procurement activity at the state and local level under UNSPSC 51332809.